Search research articles
Contact Us
Filters
Showing results (351-360 of 443) with videos related to
Page
of 45
Sort By:
American Journal of Hematology
|
November 18, 2022
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT
Michele Wieczorek, Myriam Labopin, Luca Castagna, et al.
American Journal of Hematology
|
June 10, 2024
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
American Journal of Hematology
|
July 12, 2025
Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Yishan Ye, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
BMC Cancer
|
April 27, 2025
Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT
Ryszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 3, 2020
Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation
Carolina Marini, Eolia Brissot, Abdulhamid Bazarbachi, et al.
Bone Marrow Transplantation
|
July 8, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT
Ryszard Swoboda, Myriam Labopin, Nicolaus Kröger, et al.
Bone Marrow Transplantation
|
May 14, 2022
Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party
Jesus Duque-Afonso, Jürgen Finke, Myriam Labopin, et al.
Bone Marrow Transplantation
|
October 7, 2022
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia
Arnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
Bone Marrow Transplantation
|
April 8, 2022
Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis
Eduardo Rodríguez-Arbolí, Myriam Labopin, Matthias Eder, et al.
Bone Marrow Transplantation
|
April 12, 2023
Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT
Arnon Nagler, Myriam Labopin, Stephan Mielke, et al.
Page
of 45
Search research articles
Search
Showing results (351-360 of 443) with videos related to
Sort By:
Page
of 45
American Journal of Hematology
|
November 18, 2022
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT
Michele Wieczorek, Myriam Labopin, Luca Castagna, et al.
American Journal of Hematology
|
June 10, 2024
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
American Journal of Hematology
|
July 12, 2025
Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Yishan Ye, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
BMC Cancer
|
April 27, 2025
Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT
Ryszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 3, 2020
Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation
Carolina Marini, Eolia Brissot, Abdulhamid Bazarbachi, et al.
Bone Marrow Transplantation
|
July 8, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT
Ryszard Swoboda, Myriam Labopin, Nicolaus Kröger, et al.
Bone Marrow Transplantation
|
May 14, 2022
Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party
Jesus Duque-Afonso, Jürgen Finke, Myriam Labopin, et al.
Bone Marrow Transplantation
|
October 7, 2022
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia
Arnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
Bone Marrow Transplantation
|
April 8, 2022
Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis
Eduardo Rodríguez-Arbolí, Myriam Labopin, Matthias Eder, et al.
Bone Marrow Transplantation
|
April 12, 2023
Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT
Arnon Nagler, Myriam Labopin, Stephan Mielke, et al.
Page
of 45